Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yafen Li

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
BMC Cancer|July 18, 2020
A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysisJin Hong, Jiahui Huang, Lili Shen, et al.
Frontiers in Oncology|August 28, 2020
Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer PatientsYujie Lu, Yiwei Tong, Jiahui Huang, et al.
American Journal of Cancer Research|February 1, 2021
MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activityXiaochen Zhai, Fengtao You, Shufen Xiang, et al.
Clinical Breast Cancer|July 10, 2021
Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast CancerMengdi Chen, Jiayi Wu, Deyue Liu, et al.
Oncology Letters|October 4, 2019
21-Gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypesWei Wang, Lin Lin, Xiaochun Fei, et al.
Oncotarget|April 14, 2017
Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patientsJiayi Wu, Yan Fang, Lin Lin, et al.
Integrative Cancer Therapies|August 19, 2017
Danggui Buxue Decoction, a Classical Formula of Traditional Chinese Medicine, Fails to Prevent Myelosuppression in Breast Cancer Patients Treated With Adjuvant Chemotherapy: A Prospective StudyJin Hong, Xiaosong Chen, Jiahui Huang, et al.
American Journal of Cancer Research|December 7, 2021
Chimeric antigen receptor T cells derived from CD7 nanobody exhibit robust antitumor potential against CD7-positive malignanciesDan Chen, Fengtao You, Shufen Xiang, et al.
Cancer Science|April 28, 2011
Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer modelMin Wei, Li Zhu, Yafen Li, et al.
Journal of Extracellular Vesicles|August 20, 2025
Targeting Reticulin 4 (RTN4) Within Small Extracellular Vesicles Combats Metastasis and Reinforces Immunotherapy in Triple-Negative Breast CancerHan Wang, Renhong Huang, Lei Luo, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
BMC Cancer|July 18, 2020
A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysisJin Hong, Jiahui Huang, Lili Shen, et al.
Frontiers in Oncology|August 28, 2020
Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer PatientsYujie Lu, Yiwei Tong, Jiahui Huang, et al.
American Journal of Cancer Research|February 1, 2021
MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activityXiaochen Zhai, Fengtao You, Shufen Xiang, et al.
Clinical Breast Cancer|July 10, 2021
Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast CancerMengdi Chen, Jiayi Wu, Deyue Liu, et al.
Oncology Letters|October 4, 2019
21-Gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypesWei Wang, Lin Lin, Xiaochun Fei, et al.
Oncotarget|April 14, 2017
Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patientsJiayi Wu, Yan Fang, Lin Lin, et al.
Integrative Cancer Therapies|August 19, 2017
Danggui Buxue Decoction, a Classical Formula of Traditional Chinese Medicine, Fails to Prevent Myelosuppression in Breast Cancer Patients Treated With Adjuvant Chemotherapy: A Prospective StudyJin Hong, Xiaosong Chen, Jiahui Huang, et al.
American Journal of Cancer Research|December 7, 2021
Chimeric antigen receptor T cells derived from CD7 nanobody exhibit robust antitumor potential against CD7-positive malignanciesDan Chen, Fengtao You, Shufen Xiang, et al.
Cancer Science|April 28, 2011
Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer modelMin Wei, Li Zhu, Yafen Li, et al.
Journal of Extracellular Vesicles|August 20, 2025
Targeting Reticulin 4 (RTN4) Within Small Extracellular Vesicles Combats Metastasis and Reinforces Immunotherapy in Triple-Negative Breast CancerHan Wang, Renhong Huang, Lei Luo, et al.
Pageof 11